Revvity Inc's ability to collect accounts receivable sequentially worsen to 4.03, pointing to a challenging and on top of that deteriorating business climate for the Laboratory Analytical Instruments industry. Revvity Inc's Accounts Receivable average collection period in the Jul 05 2026 quarter, has increased to 91 days, from 87 days, in the Apr 05 2026 quarter.

If we take a look into Healthcare sector 442 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jul 05 2026 from 2876 to 2953.

What is Receivable Turnover Ratio?
What is Revvity Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RVTY Receivables Turnover Ratio	(Jul 05 2026) II. Quarter	(Apr 05 2026) I. Quarter	(Dec 28 2025) IV. Quarter	(Sep 28 2025) III. Quarter	(Jun 29 2025) II. Quarter
Y / Y Receivable Change	17.58 %	11.98 %	17.75 %	12.97 %	10.66 %
Y / Y Revenue Change	1.31 %	6.97 %	5.85 %	2.18 %	4.13 %
Receivable Turnover Ratio (TTM)	4.03	4.18	4.23	4.34	4.45
RVTY's Total Ranking	# 2953	# 2876	# 2501	# 2710	# 2444
Accounts Receivable average collection period days	91	87	86	84	82
Seq. Receivable Change	12.44 %	-7.16 %	9.47 %	2.89 %	7.08 %
Seq. Revenue Change	2.61 %	-7.89 %	10.46 %	-2.96 %	8.35 %

Receivable Turnover Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 19
Healthcare Sector	# 443
Overall Market	# 2953

Receivable Turnover Ratio Statistics
High	Average	Low
6	4.99	4.03
(Jul 02 2023)		(Jul 05 2026)

RVTY Company Profile • Back to RVTY Efficiency Comparisons • Compare RVTY Receivables Turnover Ratio to its Competitors

Financial Statements
Revvity Inc's Accounts Receivable	$ 777 Millions	Visit RVTY's Balance sheet
Revvity Inc's Sales TTM	$ 2,912 Millions	Visit RVTY's Income Statement
Sources of RVTY's Revenues		Visit RVTY's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
RVTY's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
RVTY's Growth Rates	RVTY's Roa	RVTY's Inventory Turnover Ratio	RVTY's Dividend Comparisons
RVTY's Profitability Ratios	RVTY's Roi	RVTY's Asset Turnover Ratio	RVTY's Dividend Growth
RVTY's Valuation Ratios	RVTY's Roe	RVTY's Financial Strength Ratios	RVTY's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jul 05 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jul 05 2026	Receivable at quarter ending Jul 05 2026
Immucell Corporation	10.30	$ 29.777 Millions	$ 2.891 Millions
Addus Homecare Corp	10.25	$ 1,475.610 Millions	$ 143.923 Millions
Dariohealth Corp	10.23	$ 21.196 Millions	$ 2.072 Millions
Biodesix Inc	10.21	$ 102.939 Millions	$ 10.081 Millions
Kestra Medical Technologies Ltd	10.00	$ 105.939 Millions	$ 10.590 Millions
United Therapeutics Corporation	9.93	$ 3,154.500 Millions	$ 317.550 Millions
Utah Medical Products Inc	9.88	$ 35.679 Millions	$ 3.612 Millions
Biolife Solutions Inc	9.67	$ 102.718 Millions	$ 10.626 Millions
The Oncology Institute Inc	9.66	$ 587.244 Millions	$ 60.780 Millions
Sharps Technology Inc	9.65	$ 1.960 Millions	$ 0.203 Millions
Encompass Health Corporation	9.57	$ 6,206.100 Millions	$ 648.325 Millions
Septerna Inc	9.42	$ 98.882 Millions	$ 10.501 Millions
Biofrontera Inc	9.33	$ 45.956 Millions	$ 4.928 Millions
Enanta Pharmaceuticals Inc	9.29	$ 65.258 Millions	$ 7.027 Millions
The Pennant Group Inc	9.27	$ 1,101.710 Millions	$ 118.798 Millions
Crinetics Pharmaceuticals Inc	9.25	$ 42.156 Millions	$ 4.558 Millions
Neuronetics Inc	9.24	$ 154.594 Millions	$ 16.732 Millions
Myomo Inc	9.24	$ 44.242 Millions	$ 4.790 Millions
Harmony Biosciences Holdings inc	9.22	$ 960.191 Millions	$ 104.164 Millions
Bioaffinity Technologies Inc	9.18	$ 5.901 Millions	$ 0.643 Millions
Pavmed Inc	9.16	$ 0.126 Millions	$ 0.014 Millions
Clene Inc	9.16	$ 0.197 Millions	$ 0.022 Millions
Ardent Health Inc	9.16	$ 6,405.940 Millions	$ 699.363 Millions
Lexicon Pharmaceuticals Inc	9.14	$ 41.469 Millions	$ 4.535 Millions
Novavax inc	9.06	$ 413.796 Millions	$ 45.668 Millions
Nuvation Bio Inc	9.05	$ 169.551 Millions	$ 18.737 Millions
Cue Biopharma Inc	9.04	$ 37.654 Millions	$ 4.165 Millions
Sunshine Biopharma Inc	9.03	$ 35.347 Millions	$ 3.916 Millions
Biocryst Pharmaceuticals Inc	9.00	$ 940.613 Millions	$ 104.543 Millions
Edwards Lifesciences Corporation	8.99	$ 6,512.500 Millions	$ 724.750 Millions

Date modified: 2026-10-05T11:03:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.